绥美凯中国上市时间

One preparation contains three antiviral drugs. One preparation is a complete treatment plan. One tablet per day can achieve the effect of cocktail therapy without food restrictions. The English name of Triumeq is Triumeq, which consists of three drugs: dolutegravir 50mg (dolutegravir) + abacavir 0.6g (abacavir) + lamivudine 0.3g (lamivudine). It is used for the treatment of HIV-1 infection. It is the only three-in-one compound drug containing dolutegravir. It takes one tablet once a day. It has the characteristics of high efficiency, good tolerance, high resistance barrier and few drug interactions. Today we will learn about the launch date of Suimeikai in China.

On January 22, 2018, GlaxoSmithKline (GSK) announced that its single-pill compound preparation Suimeikan, which is based on the new generation integrase inhibitor dolutegravir (DTG) for the treatment of HIV, was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China. AIDS is generally recognized as a chronic disease. For chronic diseases, patient compliance is particularly important. Suimeikai takes one pill once a day, which reduces the frequency and dosage of medication and significantly enhances patient compliance.

Trimicay is a once-daily three-in-one drug developed by ViiV Healthcare, a joint venture between GlaxoSmithKline and Pfizer. The drug is based on the treatment regimen of the integrase inhibitor Tivicay (Dolutegravir) and also contains two nucleoside reverse transcriptase inhibitors, Abacavir and Lamivudine. Trimicay was approved by the FDA on August 27, 2014. 

The adverse reactions of Trimax include gastrointestinal tract - nausea, vomiting, diarrhea, abdominal pain, mouth ulcer; neurology/psychiatry - headache, paresthesia; hematology - lymphopenia; liver/pancreas - increased liver function indicators; muscle and bone - myalgia, myolysis, arthralgia, increased creatine phosphatase; respiratory tract - dyspnea, sore throat, cough, influenza-like syndrome; skin - rash (usually maculopapular rash and urticaria) ; Urology - elevated creatinine, renal failure; Other - fever, lethargy, malaise, edema, lymphadenopathy, hypotension, conjunctivitis, allergies.

The above is the content of the listing, I hope it can help you!